AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...

AstraZeneca PLC shed £15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company said its lead product candidate ...

Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.

Mr Soriot used every defence trick in the book, including playing the British heritage card ... business at all. Getty Images Last week, Italian police raided a plant where 29 million AstraZeneca ...

Among the companies with reports and trading updates today are AstraZeneca, Kingfisher, SSP Group, Pennon, CVS Group and Naked Wines. Read the Tuesday 21 May Business Live blog below.

AstraZeneca (GB:AZN) has released an update. AstraZeneca remains committed to delivering its innovative medicines in China despite ongoing ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

Emissions caused by business travel globally decreased from 314,000 metric tons in 2019 to 76,000 in 2020 and again to 72,000 in 2021, according to AstraZeneca’s 2021 sustainability report. The report ...

AstraZeneca said on Wednesday the company's China President Leon Wang is currently under investigation and is cooperating with Chinese authorities.

Steven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was ...

AstraZeneca, the UK’s largest drugmaker ... Gilead has performed well in recent years and is considered a more profitable business than most big Pharma companies. The group achieved a net ...